Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-15

Clinical Trial Update: Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is comparing the efficacy of Simbrinza and Rocklatan against Cosopt and Latanoprost for open-angle glaucoma and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cosopt (dorzolamide/timolol)
  • Latanoprost (Latanoprost)
  • ROCKLATAN (Netarsudil and latanoprost ophthalmic solution, 0.02%/0.005%)
  • Simbrinza (brinzolamide/brimonidine)

Snippet

Sponsor: Prairie Eye Center | Conditions: Open Angle Glaucoma | Phase 4 | Status: RECRUITING